Setting the stage for biosimilar monoclonal antibodies

Nat Biotechnol. 2012 Dec;30(12):1179-85. doi: 10.1038/nbt.2447.

Authors

Christian K Schneider¹, Camille Vleminckx, Iordanis Gravanis, Falk Ehmann, Jean-Hugues Trouvin, Martina Weise, Steffen Thirstrup

Affiliation

¹ Danish Health and Medicines Authority, Copenhagen, Denmark. [email protected]

PMID: 23222783
DOI: 10.1038/nbt.2447

No abstract available

MeSH terms

Antibodies, Monoclonal*
Biosimilar Pharmaceuticals*
Biotechnology
Drug Approval* / legislation & jurisprudence
Drug Labeling
European Union
Guidelines as Topic
Humans

Substances

Antibodies, Monoclonal
Biosimilar Pharmaceuticals